Anti-CD40 therapy extends renal allograft survival in rhesus macaques1-Reference-Cited by-同舟云学术

Anti-CD40 therapy extends renal allograft survival in rhesus macaques1

Published:2002-10 Issue:7 Volume:74 Page:933-940
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Pearson Thomas C.,Trambley Joel,Odom Kris,Anderson Daniel C.,Cowan Shannon,Bray Robert,Lin Angello,Hollenbaugh Diane,Aruffo Alejandro,Siadak Anthony W.,Strobert Elizabeth,Hennigar Randall,Larsen Christian P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference26 articles.

1. The B7 and CD28 receptor families

2. Cutting Edge: Administration of Anti-CD40 Ligand and Donor Bone Marrow Leads to Hemopoietic Chimerism and Donor-Specific Tolerance Without Cytoreductive Conditioning

3. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

4. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand

5. New perspectives of C1328-137-mediated T cell costimulation

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developments in kidney xenotransplantation;Frontiers in Immunology;2024-01-11

2. CD40-CD40L Blockade: Update on Novel Investigational Therapeutics for Transplantation;Transplantation;2022-12-23

3. FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies;International Journal of Molecular Sciences;2022-10-25

4. Investigational drugs for the treatment of kidney transplant rejection;Expert Opinion on Investigational Drugs;2022-10-03

5. Immunosuppression Profile of CFZ533 (Iscalimab), a Non-Depleting Anti-CD40 Antibody, and the Presence of Opportunistic Infections in a Rhesus Monkey Toxicology Study;Toxicologic Pathology;2022-06-22